AU2001280588A1 - Methods of modulating angiogenesis - Google Patents

Methods of modulating angiogenesis

Info

Publication number
AU2001280588A1
AU2001280588A1 AU2001280588A AU8058801A AU2001280588A1 AU 2001280588 A1 AU2001280588 A1 AU 2001280588A1 AU 2001280588 A AU2001280588 A AU 2001280588A AU 8058801 A AU8058801 A AU 8058801A AU 2001280588 A1 AU2001280588 A1 AU 2001280588A1
Authority
AU
Australia
Prior art keywords
methods
modulating angiogenesis
angiogenesis
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280588A
Inventor
George Liang King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joslin Diabetes Center Inc
Original Assignee
Joslin Diabetes Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joslin Diabetes Center Inc filed Critical Joslin Diabetes Center Inc
Publication of AU2001280588A1 publication Critical patent/AU2001280588A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
AU2001280588A 2000-07-18 2001-07-18 Methods of modulating angiogenesis Abandoned AU2001280588A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21924500P 2000-07-18 2000-07-18
US60219245 2000-07-18
PCT/US2001/022507 WO2002006516A1 (en) 2000-07-18 2001-07-18 Methods of modulating angiogenesis

Publications (1)

Publication Number Publication Date
AU2001280588A1 true AU2001280588A1 (en) 2002-01-30

Family

ID=22818482

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280588A Abandoned AU2001280588A1 (en) 2000-07-18 2001-07-18 Methods of modulating angiogenesis

Country Status (3)

Country Link
US (2) US20020048582A1 (en)
AU (1) AU2001280588A1 (en)
WO (1) WO2002006516A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165158A1 (en) * 2001-03-27 2002-11-07 King George L. Methods of modulating angiogenesis
US20040259816A1 (en) * 2002-10-01 2004-12-23 Pandol Stephen J. Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
WO2005065666A1 (en) * 2003-12-22 2005-07-21 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Us of a pkc-delta inhibitor for the inhibition of metastatic melanoma
WO2005107789A1 (en) * 2004-04-30 2005-11-17 The Board Of Trustees Of The Leland Stanford Junior University Use of delta pkc peptides for modulation of reactive oxigen species
JP2008526750A (en) * 2005-01-04 2008-07-24 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ How to increase cerebral blood flow
GB0704678D0 (en) 2007-03-09 2007-04-18 Univ Bristol Pro- and anti-angiogenic treatments
WO2009111169A2 (en) * 2008-02-29 2009-09-11 Bausch & Lomb Incorporated Compositions comprising pkc-delta modulators and methods for ocular neuroprotection
US20120208750A1 (en) * 2009-09-29 2012-08-16 Joslin Diabetes Center, Inc. Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
US20180066327A1 (en) * 2015-03-13 2018-03-08 Joslin Diabetes Center, Inc. Methods to Accelerate Wound Healing in Diabetic Subjects

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5959096A (en) * 1992-03-16 1999-09-28 Isis Pharmaceuticals, Inc. Antisense oligonucleotides against human protein kinase C

Also Published As

Publication number Publication date
US7410756B2 (en) 2008-08-12
US20020048582A1 (en) 2002-04-25
WO2002006516A1 (en) 2002-01-24
US20030211109A1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
AU2001276934A1 (en) Methods of modulating fibrosis
AU2001289085A1 (en) Antisense modulation of flip-c expression
AU2002213467A1 (en) Modulation of ccr4 function
AU4678601A (en) Resectoscope
AU3495200A (en) Actuation of downhole devices
AU2001265089A1 (en) Rc-timer scheme
AU2001291019A1 (en) Method of modulating neovascularization
AU2002306918A1 (en) Methods of modulating angiogenesis
AU2001292864A1 (en) Methods and compositions for modulating angiogenesis
AU5562999A (en) Methods of modulating of angiogenesis
AU3053102A (en) Methods for modulating angiogenesis
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001227847A1 (en) Antisense modulation of pepck-cytosolic expression
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001254731A1 (en) Substituted phenyluracils
AU2001280588A1 (en) Methods of modulating angiogenesis
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001286061A1 (en) Applicator
AU2001271426A1 (en) Modulation of apoptosis
AU2001287136A1 (en) Antisense modulation of glioma-associated oncogene-1 expression
AU2001265935A1 (en) Production of biohydrolysates
AU2001284047A1 (en) Butinol I esterase
AU2002307413A1 (en) Modulators of angiogenesis
AU2002222927A1 (en) Method of making hydrofluorocarbons
AU2002245089A1 (en) Antisense modulation of cytohesin-1 expression